[go: up one dir, main page]

AR004371A1 - Un metodo para reducir el tamano de un infarto en un sujeto afectado de enfermedad cardiaca isquemica. - Google Patents

Un metodo para reducir el tamano de un infarto en un sujeto afectado de enfermedad cardiaca isquemica.

Info

Publication number
AR004371A1
AR004371A1 ARP960105604A ARP960105604A AR004371A1 AR 004371 A1 AR004371 A1 AR 004371A1 AR P960105604 A ARP960105604 A AR P960105604A AR P960105604 A ARP960105604 A AR P960105604A AR 004371 A1 AR004371 A1 AR 004371A1
Authority
AR
Argentina
Prior art keywords
size
heart disease
ischemic heart
infarction
reduce
Prior art date
Application number
ARP960105604A
Other languages
English (en)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR004371A1 publication Critical patent/AR004371A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Se revela un método para reducir el tamano de un infarto en un sujeto afectado de enfermedad cardíaca isquémica, en donde dicho método usa comoagente activo un derivado carboestirilo.
ARP960105604A 1995-12-12 1996-11-12 Un metodo para reducir el tamano de un infarto en un sujeto afectado de enfermedad cardiaca isquemica. AR004371A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/570,767 US5700803A (en) 1995-12-12 1995-12-12 Method for reducing infarct size in subjects afflicted with ischemic heart disease

Publications (1)

Publication Number Publication Date
AR004371A1 true AR004371A1 (es) 1998-11-04

Family

ID=24280985

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105604A AR004371A1 (es) 1995-12-12 1996-11-12 Un metodo para reducir el tamano de un infarto en un sujeto afectado de enfermedad cardiaca isquemica.

Country Status (9)

Country Link
US (1) US5700803A (es)
EP (1) EP0782856A1 (es)
JP (1) JP4045376B2 (es)
KR (1) KR970032865A (es)
CN (1) CN1157718A (es)
AR (1) AR004371A1 (es)
AU (1) AU7413796A (es)
BR (1) BR9605969A (es)
CA (1) CA2192518A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4120713B2 (ja) * 1997-09-04 2008-07-16 大塚製薬株式会社 多発性硬化症治療剤
US5998386A (en) * 1997-09-19 1999-12-07 Feldman; Arthur M. Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue
KR100446432B1 (ko) * 2001-08-13 2004-08-30 한국화학연구원 2-벤조티아졸 카바페넴 유도체 및 그의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138971T3 (es) * 1991-07-03 2000-02-01 Otsuka Pharma Co Ltd Regulador de la apoptosis.
US5504093A (en) * 1994-08-01 1996-04-02 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication

Also Published As

Publication number Publication date
CA2192518A1 (en) 1997-06-13
EP0782856A1 (en) 1997-07-09
BR9605969A (pt) 1998-08-18
JPH09165338A (ja) 1997-06-24
JP4045376B2 (ja) 2008-02-13
KR970032865A (ko) 1997-07-22
CN1157718A (zh) 1997-08-27
MX9606345A (es) 1997-10-31
AU7413796A (en) 1997-06-19
US5700803A (en) 1997-12-23

Similar Documents

Publication Publication Date Title
AR022329A1 (es) Metodo para la preparacion de 5-cianoftalida
ES2162047T3 (es) Oxazolidinonas con resto diazinilo y carbazinilo espirociclico y biciclico.
PT1017692E (pt) 4-heteroaril-tetrahidroquinolinas e sua aplicacao como inibidores da proteina de transferencia de ester de colesterol (ctep)
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
NO2012015I2 (no) Dapoxetine
EA199700437A1 (ru) Микроинкапсулированные лактобациллы для медицинского применения
PA8514401A1 (es) Nuevos derivados de piperazina
EA200401522A1 (ru) Противотуберкулёзный препарат: композиции и способы
PA8474201A1 (es) Jarabe antihistaminico estabilizado
DK0475577T3 (da) Hydrogenerede rapamycinderivater
CL2008003939A1 (es) Uso de escitalopram o una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento de ansiedad social (divisional de la solicitud 1799-00).
NZ517039A (en) Intravaginal clindamycin ovule composition, where the clindamycin is dispersed in a hard fat suppository base
AR013519A1 (es) Composiciones orales de levosimendan
EP1508570A4 (en) NEW PHYSIOLOGICAL ACTIVE SUBSTANCES
PT952835E (pt) Metodo de tratamento de doenca cardiaca causada por chlamidia pneumoniae
AU652778B2 (en) Treatment composition
PT1150686E (pt) Matriz directamente compressivel para libertacao controlada de doses diarias unitarias de claritromicina
AR022588A1 (es) Derivados de mevinolina
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
DK1305037T3 (da) Smertestillende medikament
ES2013796A6 (es) Agente cosmetico a base de derivados de pirimidina y retinoides, y procedimiento para prepararlo.
NO20002405L (no) Superelastisk, lettvekts bøyle for haspelsnelle
AR004371A1 (es) Un metodo para reducir el tamano de un infarto en un sujeto afectado de enfermedad cardiaca isquemica.
ES461077A1 (es) Procedimiento para la preparacion de 2-bencilpirrolidinas.
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.